Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending March 2027

Overview of Results

Fukuda Denshi Co., Ltd. posted net sales of 64,688 million yen for the interim period of the fiscal year ending March 2027, a slight decrease of 0.2% year-over-year, while ordinary income was 10,974 million yen (an increase of 0.4% YoY) and operating income was 10,563 million yen (a decrease of 0.9% YoY), representing only marginal changes. By segment, therapeutic devices maintained stable growth and consumables also saw slight increases; however, clinical laboratory testing equipment declined, affecting the overall composition. Interim net income was 7,263 million yen, down 4.2% year-over-year. Full-year forecasts remain unchanged from those announced. The financial position is sound, with total assets of 231,532 million yen and an equity ratio of 84.8%.

Shareholder and Capital Policy Developments

There is no change to the previously announced dividend policy. The current dividend structure assumes an ordinary dividend of 80 yen and a special dividend of 35 yen at the end of the second quarter (full-year plan unchanged). Treasury stock as of the interim period-end amounted to 10,678,419 shares, and shareholders' equity including treasury stock was 180,716 million yen. An extraordinary general meeting of shareholders is scheduled, with a proposal to elect one statutory auditor. Over the long term, maintaining robust cash flows is considered important given factors such as digital transformation in the medical device market.